论文部分内容阅读
一份发表在近期出版的《糖尿病治疗》杂志上的研究报告表明,对于既往妊娠糖尿病的拉丁美洲妇女来说,使用安宫黄体酮(DMPA)避孕药物与其糖尿病发病风险增加相关联。Anny Hui Xiang 医生在接受路透健康记者采访时指出,观察发现安宫黄体酮和母乳喂养或安宫黄体酮和高水平甘油三酯含量可能与糖尿病发病风险增加相关联;但这一结果最终还有待于一项随机对照临床试验加以验证。来自于美国南加利福尼亚大学 KecK 医学院的Xiang 医生及其同事对526例以前曾有妊娠糖尿病
A study published in a recently published issue of Diabetes Therapeutics has shown that, for Latin American women with previous gestational diabetes, use of medroxyprogesterone (DMPA) contraceptives is associated with an increased risk of developing diabetes. In an interview with Reuters Health, Dr Anny Hui Xiang pointed out that the observation that there is a correlation between orphan progesterone and breast-feeding or progesterone and high triglyceride levels may be associated with an increased risk of developing diabetes, but this result is still to be finalized In a randomized controlled clinical trial to be verified. Dr Xiang from the KecK School of Medicine, University of Southern California, and colleagues evaluated 526 previously gestational diabetes mellitus